Nathan Smith ISCT ANZ - BAA Joint Scientific Meeting 2022

Nathan Smith

Nathan Smith has over 18 years’ experience within the cell therapy and biopharma industries in many different management roles. He graduated from Penn State University in the US with a bachelor’s degree in chemical engineering, focusing on bioprocessing, with a minor in biochemistry and molecular biology. His previous career stops at multinational companies such as GlaxoSmithKline, BioReliance, Mesoblast and Sanofi Genzyme has prepared him for his current role at Cell Therapies, where he manages all business development and industry collaborations.

Abstracts this author is presenting: